Cisplatin (Cp), a chemotherapeutic agent, interacts with purines on tumor DNA, causing tumor cell apoptosis. However, cisplatin has the characteristics of non-specific distribution and lack of selectivity, resulting in systemic toxicity. Moreover, it cannot maintain the drug’s high concentration in the tumor-weak acid environment. These flaws of cisplatin restrict its use in clinical applications. Therefore, a pH-responsive carbon nanotube-modified nano-drug delivery system (CNTs/Gel/Cp) was constructed in this study using gelatin (Gel)-modified carbon nanotubes (CNTs/Gel) loaded with cisplatin to release drugs precisely and slowly, preventing premature inactivation and maintaining an effective concentration. When M_Cp:M_CNTs/Gel = 1:1, the drug reaches the highest loading rate and entrapment efficiency. To achieve the sustained-release effect, CNTs/Gel/Cp can release the medicine steadily for a long time in a pH environment of 6.0. Additionally, CNTs/Gel/Cp display antitumor properties comparable to cisplatin in a manner that varies with the dosage administered. These findings indicate that CNTs/Gel/Cp have an effective, sustained release of cisplatin and a good antitumor effect, providing a theoretical and experimental basis for the clinical application of modified carbon nanotubes (CNTs) as a new drug delivery system.

Poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) are versatile drug nanocarriers with a wide spectrum of applications owing to their extensive advantages, including biodegradability, non-toxic side effects, and low immunogenicity. Among the numerous nanoparticle preparation methods available for PLGA NPs (the hydrophobic polymer), one of the most extensively utilized preparations is the sonicated-emulsified solvent evaporation method, owing to its simplicity, speed, convenience, and cost-effectiveness. Nevertheless, several factors can influence the outcomes, such as the types of concentration of the surfactants and organic solvents, as well as the volume of the aqueous phase. The objective of this article is to explore the influence of these factors on the properties of PLGA NPs and their drug release behavior following encapsulation. Herein, PLGA NPs were fabricated using bovine serum albumin (BSA) as a surfactant to investigate the impact of influencing factors, including different water-soluble organic solvents such as propylene carbonate (PC), ethyl acetate (PA), and dichloromethane (DCM). Notably, the size of PLGA NPs was smaller in the EA group compared to that in the DCM group. Moreover, PLGA NPs showed excellent stability, ascribed to the presence of the BSA surfactant. Furthermore, PLGA NPs were co-loaded with varying concentrations of hydrophilic drugs (doxorubicin hydrochloride) and hydrophobic drugs (celecoxib), and exhibited pH-sensitive drug release behavior in PBS with pH 7.4 and pH 5.5.

The rising prevalence of antibiotic resistance necessitates innovative alternatives for managing polymicrobial oral infections. Photothermal therapy (PTT) emerges as a revolutionary approach that transcends conventional antimicrobial limitations by leveraging near-infrared (NIR)-activated photothermal agents to generate localized hyperthermia, enabling precise biofilm eradication while circumventing systemic drug resistance. The modality capitalizes on the anatomical accessibility of oral tissues and the optical transparency of dental structures, allowing spatiotemporal control over pathogenic niches from superficial caries biofilms to deep periodontal pockets. Recent advances in nanoplatform engineering have unlocked multifunctional PTT systems capable of synergizing thermal ablation with immunomodulation, biofilm matrix penetration, and even tissue regeneration, addressing the dual challenges of microbial persistence and host inflammatory damage. However, clinical translation remains hindered by unresolved technical barriers, including optimal thermal dosage calibration, lesion-specific material design, and long-term biosafety assessment. This review systematically dissects cutting-edge photothermal strategies across the oral infectious spectrum (dental caries, endodontic infections, periodontitis, and peri-implantitis) while critically evaluating their mechanistic innovations in overcoming antibiotic limitations. We further propose a roadmap for next-generation smart PTT systems integrating stimulus-responsive materials and microbiome-aware therapeutic paradigms to achieve personalized oral infection management.

The long-term stability of dentin bonding is equally crucial for minimally invasive aesthetic restoration. Although the dentin bonding meets clinical stand

Carbon nanotubes (CNTs) have attracted great interest in biomedical fields. However, the potential toxicity and poor dispersion of CNTs have greatly limited its application. In this work, a mussel-inspired method combined with the “thiol-Michael” click reaction was used to modify the surface of CNT and improve its properties. Firstly, a CNT was treated with dopamine, and then alginate grafted with L-cysteine was anchored onto the surface of CNT via click reaction, which realized the long-time dispersion of CNT in water. Furthermore, the in vitro test also demonstrated that the alginate may improve the biocompatibility of CNT, and thus may broaden the application of CNT in the biomedical field.